Fingerprint
Dive into the research topics of 'Erratum: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium (Investigational New Drugs DOI: 10.1007/s10637-010-9420-8)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically